Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4411(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yI)-4-hydroxyphenyl)acrylic Acid (CD3254)

被引:28
作者
Jurutka, Peter W. [1 ]
Kaneko, Ichiro [1 ]
Yang, Joanna [1 ]
Bhogal, Jaskaran S. [1 ]
Swierski, Johnathon C. [1 ]
Tabacaru, Christa R. [1 ]
Montano, Luis A. [1 ]
Huynh, Chanh C. [1 ]
Jama, Rabia A. [1 ]
Mahelona, Ryan D. [1 ]
Sarnowski, Joseph T. [1 ]
Marcus, Lisa M. [1 ]
Quezada, Alexis [1 ]
Lemming, Brittney [1 ]
Tedesco, Maria A. [1 ]
Fischer, Audra J. [1 ]
Mohamed, Said A. [1 ]
Ziler, Joseph W. [2 ]
Ma, Ning [3 ]
Gray, Geoffrey M. [3 ]
van der Vaart, Arjan [3 ]
Marshall, Pamela A. [1 ]
Wagner, Carl E. [1 ]
机构
[1] Arizona State Univ, New Coll Interdisciplinary Arts & Sci, Sch Math & Nat Sci, Glendale, AZ 85306 USA
[2] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA
[3] Univ S Florida, Dept Chem, Tampa, FL 33620 USA
基金
美国国家卫生研究院;
关键词
VITAMIN-D-RECEPTOR; ENHANCES BASOLATERAL EFFLUX; THYROID-HORMONE RECEPTOR; 9-CIS-RETINOIC ACID; GROWTH-INHIBITION; CRYSTAL-STRUCTURE; PACLITAXEL TAXOL; DNA-BINDING; ACTIVATION; LIGANDS;
D O I
10.1021/jm4008517
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three unreported analogues of 44143,5,5,8,8pentamethyl-5-6-7-8-tetrahydro-2-naphthypethynyllbenzoic acid (1), otherwise known as bexarotene, as well as four novel analogues of (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-y1)-4-hydroxyphenyl)acrylic acid (CD3254), are described and evaluated for their retinoid X receptor (RXR) selective agonism. Compound 1 has FDA approval as a treatment for cutaneous T-cell lymphoma (CTCL), although treatment with 1 can elicit side-effects by disrupting other RXR-heterodimer receptor pathways. Of the seven modeled novel compounds, all analogues stimulate RXR-regulated transcription in mammalian 2 hybrid and RXRE-mediated assays, possess comparable or elevated biological activity based on EC50 profiles, and retain similar or improved apoptotic activity in CTCL assays compared to 1. All novel compounds demonstrate selectivity for RXR and minimal crossover onto the retinoic acid receptor (RAR) compared to all-trans-retinoic acid, with select analogues also reducing inhibition of other RXR-dependent pathways (e.g., VDR-RXR). Our results demonstrate that further improvements in biological potency and selectivity of bexarotene can be achieved through rational drug design.
引用
收藏
页码:8432 / 8454
页数:23
相关论文
共 74 条
[1]   Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase [J].
Adams, Nicholas D. ;
Adams, Jerry L. ;
Burgess, Joelle L. ;
Chaudhari, Amita M. ;
Copeland, Robert A. ;
Donatelli, Carla A. ;
Drewry, David H. ;
Fisher, Kelly E. ;
Hamajima, Toshihiro ;
Hardwicke, Mary Ann ;
Huffman, William F. ;
Koretke-Brown, Kristin K. ;
Lai, Zhihong V. ;
McDonald, Octerloney B. ;
Nakamura, Hiroko ;
Newlander, Ken A. ;
Oleykowski, Catherine A. ;
Parrish, Cynthia A. ;
Patrick, Denis R. ;
Plant, Ramona ;
Sarpong, Martha A. ;
Sasaki, Kosuke ;
Schmidt, Stanley J. ;
Silva, Domingos J. ;
Sutton, David ;
Tang, Jun ;
Thompson, Christine S. ;
Tummino, Peter J. ;
Wang, Jamin C. ;
Xiang, Hong ;
Yang, Jingsong ;
Dhanak, Dashyant .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (10) :3973-4001
[2]   RAR and RXR modulation in cancer and metabolic disease [J].
Altucci, Lucia ;
Leibowitz, Mark D. ;
Ogilvie, Kathleen M. ;
de Lera, Angel R. ;
Gronemeyer, Hinrich .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) :793-810
[3]   A Review: Treatment of Alzheimer's Disease Discovered in Repurposed Agents [J].
Appleby, Brian S. ;
Nacopoulos, Dimitrios ;
Milano, Nicholas ;
Zhong, Kate ;
Cummings, Jeffrey L. .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 35 (1-2) :1-22
[4]   DESIGN AND SYNTHESIS OF POTENT RETINOID-X RECEPTOR-SELECTIVE LIGANDS THAT INDUCE APOPTOSIS IN LEUKEMIA-CELLS [J].
BOEHM, MF ;
ZHANG, L ;
ZHI, L ;
MCCLURG, MR ;
BERGER, E ;
WAGONER, M ;
MAIS, DE ;
SUTO, CM ;
DAVIES, PJA ;
HEYMAN, RA ;
NADZAN, AM .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (16) :3146-3155
[5]   SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL RETINOID-X RECEPTOR-SELECTIVE RETINOIDS [J].
BOEHM, MF ;
ZHANG, L ;
BADEA, BA ;
WHITE, SK ;
MAIS, DE ;
BERGER, E ;
SUTO, CM ;
GOLDMAN, ME ;
HEYMAN, RA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (18) :2930-2941
[6]   Biochemical pathways of caspase activation during apoptosis [J].
Budihardjo, I ;
Oliver, H ;
Lutter, M ;
Luo, X ;
Wang, XD .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :269-290
[7]   Differentiation and growth inhibition mediated via the RXR:PPARγ heterodimer in colon cancer [J].
Cesario, Rosemary M. ;
Stone, Jessica ;
Yen, Wan-Ching ;
Bissonnette, Reid P. ;
Lamph, William W. .
CANCER LETTERS, 2006, 240 (02) :225-233
[8]   ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models [J].
Cramer, Paige E. ;
Cirrito, John R. ;
Wesson, Daniel W. ;
Lee, C. Y. Daniel ;
Karlo, J. Colleen ;
Zinn, Adriana E. ;
Casali, Brad T. ;
Restivo, Jessica L. ;
Goebel, Whitney D. ;
James, Michael J. ;
Brunden, Kurt R. ;
Wilson, Donald A. ;
Landreth, Gary E. .
SCIENCE, 2012, 335 (6075) :1503-1506
[9]   Synthesis, crystal structure analysis, and pharmacological characterization of disila-bexarotene, a disila-analogue of the RXR-selective retinoid agonist bexarotene [J].
Daiss, JO ;
Burschka, C ;
Mills, JS ;
Montana, JG ;
Showell, GA ;
Fleming, I ;
Gaudon, C ;
Ivanova, D ;
Gronemeyer, H ;
Tacke, R .
ORGANOMETALLICS, 2005, 24 (13) :3192-3199
[10]   CONFORMATIONAL EFFECTS ON RETINOID RECEPTOR SELECTIVITY .2. EFFECTS OF RETINOID BRIDGING GROUP ON RETINOID-X-RECEPTOR ACTIVITY AND SELECTIVITY [J].
DAWSON, MI ;
JONG, L ;
HOBBS, PD ;
CAMERON, JF ;
CHAO, WR ;
PFAHL, M ;
LEE, MO ;
SHROOT, B ;
PFAHL, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3368-3383